Clinical Trial Update: GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing tesaglitazar in combination with insulin for Type 2 Diabetes Mellitus was terminated; no efficacy results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Tesaglitazar (tesaglitazar)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED